Sherry Ferguson, PhD
Affiliations: | Neurotoxicology | National Center for Toxicologicsl Research/ FDA |
Google:
"Sherry Ferguson"Mean distance: 19.85 (cluster 19)
Children
Sign in to add trainee| John J. Panos | post-doc | 2012- | National Center for Toxicological Research/ FDA |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ferguson SA, Panos JJ, Sloper D, et al. (2021) Alzheimer's disease: a step closer to understanding type 3 diabetes in African Americans. Metabolic Brain Disease |
| Ferguson SA, Varma V, Sloper D, et al. (2019) Increased inflammation in BA21 brain tissue from African Americans with Alzheimer's disease. Metabolic Brain Disease |
| Ferguson SA, Panos JJ, Sloper D, et al. (2017) Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad |
| Ferguson SA, Panos J, Sloper DT, et al. (2016) P1-330: Altered Levels of ABETA42 in BA21 Brain Region of African Americans Relative to Caucasians with Alzheimer's Disease Alzheimer's & Dementia. 12: P554-P555 |
| Ferguson SA, Law CD, Sarkar S. (2015) Chronic MPTP treatment produces hyperactivity in male mice which is not alleviated by concurrent trehalose treatment. Behavioural Brain Research. 292: 68-78 |
| Panos JJ, O'Callaghan JP, Miller DB, et al. (2014) Effects of developmental methylphenidate (MPH) treatment on monoamine neurochemistry of male and female rats. Neurotoxicology and Teratology. 45: 70-4 |
| Panos JJ, Law CD, Ferguson SA. (2014) Effects of perinatal methylphenidate (MPH) treatment in male and female Sprague-Dawley offspring. Neurotoxicology and Teratology. 42: 9-16 |